Investors of Park Ha Biological Technology Co., Ltd. Urged to Act Before Class Action Deadline

Critical Alert for Investors of Park Ha Biological Technology Co., Ltd.

Institutional investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) are facing a significant deadline regarding a class action lawsuit. SueWallSt has issued reminders for those who acquired securities between December 27, 2024, and July 8, 2025, emphasizing the urgent need to act before the September 28, 2026, cutoff date to be eligible as lead plaintiffs.

On July 8, 2025, BYAH shares plummeted approximately 93%, closing at $2.99 compared to a previous high of $41.01, leading to losses exceeding $1 billion in market capitalization within one trading session. The lawsuit points to undisclosed factors surrounding the company's structure that left institutional holders exposed to severe market manipulation.

Class Action Overview

The legal action, initiated by shareholders, alleges that Park Ha Biological Technology Co., Ltd. misled investors by failing to disclose the manipulative practices that impacted security trading. Investors were reportedly unaware that a modest position could be driven by low public float numbers, contributing significantly to its dramatic stock price decline.

Joseph E. Levi, Esq., a key figure in the proceedings, stressed the importance of institutional investors in these types of class actions. His firm, Levi & Korsinsky LLP, stands ready to assist affected investors in assessing their potential losses. Individuals or institutions that sold BYAH at a loss might still be eligible to claim based on their purchase dates during the class period.

Obligations and Recovery Pathways

Investment boards and trustees have a fiduciary duty to actively manage and pursue recoverable claims, which may include losses incurred from securities litigation. Currently, institutions with the most documented losses are in prime positions to be appointed as lead plaintiffs, who will oversee counsel, litigation strategies, and settlement discussions.

SueWallSt extends an offer for no-cost analysis of loss assessments for interested parties. To facilitate future claims, investors are encouraged to gather essential brokerage records detailing their purchase dates and share volumes.

Questions and Answers

What misstatements are alleged in the lawsuit?
The lawsuit contends that Park Ha Biological Technology Co., Ltd. issued materially misleading statements regarding its securities activities, specifically pointing to a lack of transparency about the low public float that enabled manipulative trading tactics.

What timeframe does the class action cover?
The class period runs from December 27, 2024, through July 8, 2025, during which time corrective disclosures surfaced, contributing to the stock's sharp decline.

Where was the class action filed?
The action is filed in the Southern District of New York, following regulations outlined in the Private Securities Litigation Reform Act of 1995.

How can investors get involved?
Affected investors should proceed to collect pertinent brokerage documentation now. SueWallSt offers a complimentary evaluation for those looking to assess their potential claims.

Conclusion

This situation emphasizes the importance of vigilance among institutional investors in maintaining transparency and accountability in their investments. The looming deadline for the class action presents a crucial opportunity for investors in Park Ha Biological Technology Co., Ltd. to pursue restitution for the significant financial losses incurred. Those interested in exploring their options further should reach out to SueWallSt for guidance.